Diabetes is a chronic condition caused by the body’s inability to produce or make use of insulin
Disease awareness section where you can access information and resources to educate and motivate people living with diabetes
Obesity has been recognised by health organisations including the WHO as a chronic disease that requires long-term management
Haemophilia is an inherited (congenital) bleeding disorder that affects males
Growth Hormone is crucial to the healthy development and functioning of the human body
HRT is used to treat climacteric symptoms of women in different stages of the menopause
Feature and point of view articles
Board of Directors and Executive Management
How we are managed, directed and controlled
Novo Nordisk Annual Report 2014
accounts for our financial, social and environmental performance during the year in one integrated report.
Annual reporting requirement by the US Securities and Exchange Commission (SEC) for foreign private issuers with equity shares listed on exchanges in the United States. Form 20-F is filed using a standardised reporting form so that investors can evaluate the company alongside US domestic equities.
Requirement according to the Danish Financial Statements Act. Reporting of compliance with Danish Corporate Governance Recommendations.
Voluntary Communication on Progress reporting in the form of the United Nations and its 10 principles in the areas of human rights, labour rights, environment and anti-corruption. As a LEAD member, Novo Nordisk provides additional progress reporting on corporate sustainability leadership and UN goals.
This reporting also fulfils the requirements of the Danish Financial Statements Act, sections 99a and 99b, on policies and actions for corporate responsibility and progress against targets for diversity in management.
Order the Annual Report 2014 in English or Novo Nordisk Årsskrift 2014 in Danish via our printer’s website.
Dette årsskrift er en dansk udgave af ledelses-
beretningen, som er indeholdt i årsrapporten for 2014 (Novo Nordisk Annual Report 2014), samt uddrag af koncernregnskabet med de finansielle, sociale og miljømæssige resultater for året.
Novo Nordisks årsrapport udarbejdes nu udelukkende på engelsk. Årsskriftet er udarbejdet i henhold til årsregnskabslovens § 149, stk. 2. I tilfælde af uoverensstemmelse mellem den danske og den engelske version er den engelske gældende.
Læsere, der ønsker at se det fulde koncernregnskab med anvendt regnskabspraksis og noter, moderselskabsregnskab samt ledelses- og revisionspåtegninger, henvises til Novo Nordisk Annual Report 2014.